Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

Market Cap	36.66B
Revenue (ttm)	4.01B
Net Income (ttm)	601.57M
Shares Out	1.11B
EPS (ttm)	0.54
PE Ratio	60.89
Forward PE	53.46
Dividend	0.50 (1.52%)
Ex-Dividend Date	n/a

Volume	11,902,400
Average Volume	5,500,197
Open	30.70
Previous Close	31.92
Day's Range	30.70 - 33.38
52-Week Range	25.51 - 38.10
Beta	0.66
RSI	70.60
Earnings Date	Mar 25, 2025

About SHE:002294

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also provides interventional medical devices for therapy of cardiovascular and cerebrovascular diseases, peripheral blood vessels, structural heart diseases, electrophysiol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 3,517
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002294

Financial Performance

In 2024, SHE:002294's revenue was 4.01 billion, an increase of 19.22% compared to the previous year's 3.37 billion. Earnings were 601.57 million, an increase of 3.71%.